Loading…

Can the choice reaction time be modified after COVID-19 diagnosis? A prospective cohort study

ABSTRACT Assessment of cognitive processing speed through choice reaction time (CRT) can be an objective tool to assess cognitive functions after COVID-19 infection. Objective: This study aimed to assess CRT in individuals after acute COVID-19 infection over 1 year. Methods: We prospectively analyze...

Full description

Saved in:
Bibliographic Details
Published in:Dementia & neuropsychologia 2022
Main Authors: Luvizutto, Gustavo José, Sisconetto, Angélica Taciana, Appelt, Pablo Andrei, Sucupira, Kelly Savana Minaré Baldo, Moura Neto, Eduardo de, Souza, Luciane Aparecida Pascucci Sande de
Format: Article
Language:Portuguese
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue
container_start_page
container_title Dementia & neuropsychologia
container_volume
creator Luvizutto, Gustavo José
Sisconetto, Angélica Taciana
Appelt, Pablo Andrei
Sucupira, Kelly Savana Minaré Baldo
Moura Neto, Eduardo de
Souza, Luciane Aparecida Pascucci Sande de
description ABSTRACT Assessment of cognitive processing speed through choice reaction time (CRT) can be an objective tool to assess cognitive functions after COVID-19 infection. Objective: This study aimed to assess CRT in individuals after acute COVID-19 infection over 1 year. Methods: We prospectively analyzed 30 individuals (male: 9, female: 21) with mild-moderate functional status after COVID-19 and 30 individuals (male: 8, female: 22) without COVID-19. Cognitive and neuropsychiatric symptoms were evaluated using the Montreal Cognitive Assessment (MoCA) and Hospital Anxiety and Depression Scale (HADS), respectively. CRT (milliseconds) was evaluated by finding the difference between the photodiode signal and the electromyographic (EMG) onset latency of anterior deltoid, brachial biceps, and triceps during the task of reaching a luminous target. CRT was evaluated three times over 1 year after COVID-19: baseline assessment (>4 weeks of COVID-19 diagnosis), between 3 and 6 months, and between 6 and 12 months. Results: The multiple comparison analysis shows CRT reduction of the anterior deltoid in the COVID-19 group at 3-6 (p=0.001) and 6-12 months (p
doi_str_mv 10.1590/1980-5764-dn-2021-0116
format article
fullrecord <record><control><sourceid>scielo</sourceid><recordid>TN_cdi_scielo_journals_S1980_57642022005004206</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><scielo_id>S1980_57642022005004206</scielo_id><sourcerecordid>S1980_57642022005004206</sourcerecordid><originalsourceid>FETCH-scielo_journals_S1980_576420220050042063</originalsourceid><addsrcrecordid>eNqVjsGKwjAQhnNwQXF9BZkXiE6qrfYkUhX3tIcVb1JiM7UR7UgShX37jSDe9zQ_8_H_fEIMFY5UmuNY5XOU6SybStPKBBMlUamsI3pv0BUD78-IqNIssklPHArdQmgIqoZtReBIV8Fy_NkrwZHgysbWlgzoOpCD4nv_tZIqB2P1qWVv_QKWcHPsbxSLjzjEDbsAPtzN76f4qPXF0-B1-2K0We-KrfSVpQuXZ767NoLy56lYPhWjd4KYIsaUTf5d-AM1UUyh</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Can the choice reaction time be modified after COVID-19 diagnosis? A prospective cohort study</title><source>PubMed (Medline)</source><source>SciELO</source><creator>Luvizutto, Gustavo José ; Sisconetto, Angélica Taciana ; Appelt, Pablo Andrei ; Sucupira, Kelly Savana Minaré Baldo ; Moura Neto, Eduardo de ; Souza, Luciane Aparecida Pascucci Sande de</creator><creatorcontrib>Luvizutto, Gustavo José ; Sisconetto, Angélica Taciana ; Appelt, Pablo Andrei ; Sucupira, Kelly Savana Minaré Baldo ; Moura Neto, Eduardo de ; Souza, Luciane Aparecida Pascucci Sande de</creatorcontrib><description>ABSTRACT Assessment of cognitive processing speed through choice reaction time (CRT) can be an objective tool to assess cognitive functions after COVID-19 infection. Objective: This study aimed to assess CRT in individuals after acute COVID-19 infection over 1 year. Methods: We prospectively analyzed 30 individuals (male: 9, female: 21) with mild-moderate functional status after COVID-19 and 30 individuals (male: 8, female: 22) without COVID-19. Cognitive and neuropsychiatric symptoms were evaluated using the Montreal Cognitive Assessment (MoCA) and Hospital Anxiety and Depression Scale (HADS), respectively. CRT (milliseconds) was evaluated by finding the difference between the photodiode signal and the electromyographic (EMG) onset latency of anterior deltoid, brachial biceps, and triceps during the task of reaching a luminous target. CRT was evaluated three times over 1 year after COVID-19: baseline assessment (&gt;4 weeks of COVID-19 diagnosis), between 3 and 6 months, and between 6 and 12 months. Results: The multiple comparison analysis shows CRT reduction of the anterior deltoid in the COVID-19 group at 3-6 (p=0.001) and 6-12 months (p&lt;0.001) compared to the control group. We also observed CRT reduction of the triceps at 6-12 months (p=0.002) and brachial biceps at 0-3 (p&lt;0.001), 3-6 (p&lt;0.001), and 6-12 months (p&lt;0.001) in the COVID-19 compared to the control group. Moderate correlations were observed between MoCA and CRT of the anterior deltoid (r=-0.63; p=0.002) and brachial biceps (r=-0.67; p=0.001) at 6–12 months in the COVID-19 group. Conclusions: There was a reduction in CRT after acute COVID-19 over 1 year. A negative correlation was also observed between MoCA and CRT only from 6 to 12 months after COVID-19 infection.</description><identifier>ISSN: 1980-5764</identifier><identifier>DOI: 10.1590/1980-5764-dn-2021-0116</identifier><language>por</language><publisher>Academia Brasileira de Neurologia, Departamento de Neurologia Cognitiva e Envelhecimento</publisher><subject>CLINICAL NEUROLOGY ; GERIATRICS &amp; GERONTOLOGY ; HEALTH CARE SCIENCES &amp; SERVICES ; MEDICINE, GENERAL &amp; INTERNAL ; NURSING ; PSYCHIATRY ; PSYCHOLOGY</subject><ispartof>Dementia &amp; neuropsychologia, 2022</ispartof><rights>This work is licensed under a Creative Commons Attribution 4.0 International License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,24150,27924,27925</link.rule.ids></links><search><creatorcontrib>Luvizutto, Gustavo José</creatorcontrib><creatorcontrib>Sisconetto, Angélica Taciana</creatorcontrib><creatorcontrib>Appelt, Pablo Andrei</creatorcontrib><creatorcontrib>Sucupira, Kelly Savana Minaré Baldo</creatorcontrib><creatorcontrib>Moura Neto, Eduardo de</creatorcontrib><creatorcontrib>Souza, Luciane Aparecida Pascucci Sande de</creatorcontrib><title>Can the choice reaction time be modified after COVID-19 diagnosis? A prospective cohort study</title><title>Dementia &amp; neuropsychologia</title><addtitle>Dement. neuropsychol</addtitle><description>ABSTRACT Assessment of cognitive processing speed through choice reaction time (CRT) can be an objective tool to assess cognitive functions after COVID-19 infection. Objective: This study aimed to assess CRT in individuals after acute COVID-19 infection over 1 year. Methods: We prospectively analyzed 30 individuals (male: 9, female: 21) with mild-moderate functional status after COVID-19 and 30 individuals (male: 8, female: 22) without COVID-19. Cognitive and neuropsychiatric symptoms were evaluated using the Montreal Cognitive Assessment (MoCA) and Hospital Anxiety and Depression Scale (HADS), respectively. CRT (milliseconds) was evaluated by finding the difference between the photodiode signal and the electromyographic (EMG) onset latency of anterior deltoid, brachial biceps, and triceps during the task of reaching a luminous target. CRT was evaluated three times over 1 year after COVID-19: baseline assessment (&gt;4 weeks of COVID-19 diagnosis), between 3 and 6 months, and between 6 and 12 months. Results: The multiple comparison analysis shows CRT reduction of the anterior deltoid in the COVID-19 group at 3-6 (p=0.001) and 6-12 months (p&lt;0.001) compared to the control group. We also observed CRT reduction of the triceps at 6-12 months (p=0.002) and brachial biceps at 0-3 (p&lt;0.001), 3-6 (p&lt;0.001), and 6-12 months (p&lt;0.001) in the COVID-19 compared to the control group. Moderate correlations were observed between MoCA and CRT of the anterior deltoid (r=-0.63; p=0.002) and brachial biceps (r=-0.67; p=0.001) at 6–12 months in the COVID-19 group. Conclusions: There was a reduction in CRT after acute COVID-19 over 1 year. A negative correlation was also observed between MoCA and CRT only from 6 to 12 months after COVID-19 infection.</description><subject>CLINICAL NEUROLOGY</subject><subject>GERIATRICS &amp; GERONTOLOGY</subject><subject>HEALTH CARE SCIENCES &amp; SERVICES</subject><subject>MEDICINE, GENERAL &amp; INTERNAL</subject><subject>NURSING</subject><subject>PSYCHIATRY</subject><subject>PSYCHOLOGY</subject><issn>1980-5764</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNqVjsGKwjAQhnNwQXF9BZkXiE6qrfYkUhX3tIcVb1JiM7UR7UgShX37jSDe9zQ_8_H_fEIMFY5UmuNY5XOU6SybStPKBBMlUamsI3pv0BUD78-IqNIssklPHArdQmgIqoZtReBIV8Fy_NkrwZHgysbWlgzoOpCD4nv_tZIqB2P1qWVv_QKWcHPsbxSLjzjEDbsAPtzN76f4qPXF0-B1-2K0We-KrfSVpQuXZ767NoLy56lYPhWjd4KYIsaUTf5d-AM1UUyh</recordid><startdate>202201</startdate><enddate>202201</enddate><creator>Luvizutto, Gustavo José</creator><creator>Sisconetto, Angélica Taciana</creator><creator>Appelt, Pablo Andrei</creator><creator>Sucupira, Kelly Savana Minaré Baldo</creator><creator>Moura Neto, Eduardo de</creator><creator>Souza, Luciane Aparecida Pascucci Sande de</creator><general>Academia Brasileira de Neurologia, Departamento de Neurologia Cognitiva e Envelhecimento</general><scope>GPN</scope></search><sort><creationdate>202201</creationdate><title>Can the choice reaction time be modified after COVID-19 diagnosis? A prospective cohort study</title><author>Luvizutto, Gustavo José ; Sisconetto, Angélica Taciana ; Appelt, Pablo Andrei ; Sucupira, Kelly Savana Minaré Baldo ; Moura Neto, Eduardo de ; Souza, Luciane Aparecida Pascucci Sande de</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-scielo_journals_S1980_576420220050042063</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>por</language><creationdate>2022</creationdate><topic>CLINICAL NEUROLOGY</topic><topic>GERIATRICS &amp; GERONTOLOGY</topic><topic>HEALTH CARE SCIENCES &amp; SERVICES</topic><topic>MEDICINE, GENERAL &amp; INTERNAL</topic><topic>NURSING</topic><topic>PSYCHIATRY</topic><topic>PSYCHOLOGY</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Luvizutto, Gustavo José</creatorcontrib><creatorcontrib>Sisconetto, Angélica Taciana</creatorcontrib><creatorcontrib>Appelt, Pablo Andrei</creatorcontrib><creatorcontrib>Sucupira, Kelly Savana Minaré Baldo</creatorcontrib><creatorcontrib>Moura Neto, Eduardo de</creatorcontrib><creatorcontrib>Souza, Luciane Aparecida Pascucci Sande de</creatorcontrib><collection>SciELO</collection><jtitle>Dementia &amp; neuropsychologia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Luvizutto, Gustavo José</au><au>Sisconetto, Angélica Taciana</au><au>Appelt, Pablo Andrei</au><au>Sucupira, Kelly Savana Minaré Baldo</au><au>Moura Neto, Eduardo de</au><au>Souza, Luciane Aparecida Pascucci Sande de</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Can the choice reaction time be modified after COVID-19 diagnosis? A prospective cohort study</atitle><jtitle>Dementia &amp; neuropsychologia</jtitle><addtitle>Dement. neuropsychol</addtitle><date>2022-01</date><risdate>2022</risdate><issn>1980-5764</issn><abstract>ABSTRACT Assessment of cognitive processing speed through choice reaction time (CRT) can be an objective tool to assess cognitive functions after COVID-19 infection. Objective: This study aimed to assess CRT in individuals after acute COVID-19 infection over 1 year. Methods: We prospectively analyzed 30 individuals (male: 9, female: 21) with mild-moderate functional status after COVID-19 and 30 individuals (male: 8, female: 22) without COVID-19. Cognitive and neuropsychiatric symptoms were evaluated using the Montreal Cognitive Assessment (MoCA) and Hospital Anxiety and Depression Scale (HADS), respectively. CRT (milliseconds) was evaluated by finding the difference between the photodiode signal and the electromyographic (EMG) onset latency of anterior deltoid, brachial biceps, and triceps during the task of reaching a luminous target. CRT was evaluated three times over 1 year after COVID-19: baseline assessment (&gt;4 weeks of COVID-19 diagnosis), between 3 and 6 months, and between 6 and 12 months. Results: The multiple comparison analysis shows CRT reduction of the anterior deltoid in the COVID-19 group at 3-6 (p=0.001) and 6-12 months (p&lt;0.001) compared to the control group. We also observed CRT reduction of the triceps at 6-12 months (p=0.002) and brachial biceps at 0-3 (p&lt;0.001), 3-6 (p&lt;0.001), and 6-12 months (p&lt;0.001) in the COVID-19 compared to the control group. Moderate correlations were observed between MoCA and CRT of the anterior deltoid (r=-0.63; p=0.002) and brachial biceps (r=-0.67; p=0.001) at 6–12 months in the COVID-19 group. Conclusions: There was a reduction in CRT after acute COVID-19 over 1 year. A negative correlation was also observed between MoCA and CRT only from 6 to 12 months after COVID-19 infection.</abstract><pub>Academia Brasileira de Neurologia, Departamento de Neurologia Cognitiva e Envelhecimento</pub><doi>10.1590/1980-5764-dn-2021-0116</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1980-5764
ispartof Dementia & neuropsychologia, 2022
issn 1980-5764
language por
recordid cdi_scielo_journals_S1980_57642022005004206
source PubMed (Medline); SciELO
subjects CLINICAL NEUROLOGY
GERIATRICS & GERONTOLOGY
HEALTH CARE SCIENCES & SERVICES
MEDICINE, GENERAL & INTERNAL
NURSING
PSYCHIATRY
PSYCHOLOGY
title Can the choice reaction time be modified after COVID-19 diagnosis? A prospective cohort study
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T17%3A00%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-scielo&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Can%20the%20choice%20reaction%20time%20be%20modified%20after%20COVID-19%20diagnosis?%20A%20prospective%20cohort%20study&rft.jtitle=Dementia%20&%20neuropsychologia&rft.au=Luvizutto,%20Gustavo%20Jos%C3%A9&rft.date=2022-01&rft.issn=1980-5764&rft_id=info:doi/10.1590/1980-5764-dn-2021-0116&rft_dat=%3Cscielo%3ES1980_57642022005004206%3C/scielo%3E%3Cgrp_id%3Ecdi_FETCH-scielo_journals_S1980_576420220050042063%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rft_scielo_id=S1980_57642022005004206&rfr_iscdi=true